Last $15.84 USD
Change Today +1.63 / 11.47%
Volume 21.9M
ACHN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:32 AM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert L. Van Nostrand BS

Director, Chairman of Audit Committee and Member of Compensation Committee, Achillion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 39 board members in 5 different organizations across 7 different industries.

See Board Relationships
57$56,007

Background*

Mr. Robert L. Van Nostrand, also known as Bob, BS served as Chief Financial Officer and Executive Vice President of Aureon Laboratories, Inc. since January 2010. Mr. Van Nostrand has responsibility for all financial aspects of the Aureon Laboratories's activities. He served as Executive Vice President and Chief Financial Officer of Aureon Biosciences, Inc., from January 2010 to July 2010. He served as the Chief Financial Officer and an Executive Vice President of Applied ...

Read Full Background

Corporate Headquarters*

300 George Street
New Haven, Connecticut 06511

United States

Phone: 203-724-6000
Fax: 203-624-7003

Board Members Memberships*

1986-Present
Independent Director and Member of Audit Committee
2006-Present
Chairman, Chairman of Audit Committee and Member of Compensation Committee
2007-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2014-Present
Director and Chairman of Audit Committee
2014-Present
Independent Director

Education*

BS
Long Island University
Unknown/Other Education
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$45,000
Total Calculated Compensation$56,007
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACHN:US $15.84 USD +1.63

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACHILLION PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.